(ABUS) Arbutus Biopharma complete technical analysis [charts+indicators] | Buy/Sell Arbutus Biopharma | (ABUS) share price targets
Complete technical analysis of Arbutus Biopharma (ABUS) by charts plus indicators, forecast predictions and share price targets for Arbutus Biopharma (ABUS)
Arbutus Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2026-01-07 View latest technical analysis
10 day averaged volume of Arbutus Biopharma is 1124481
| Date | Daily Closing Price | Open | High | Low | Volume |
| 07 Wed Jan 2026 | 4.88 | 4.81 | 5.00 | 4.79 | 1.398 times |
| 06 Tue Jan 2026 | 4.79 | 4.75 | 4.83 | 4.65 | 0.772 times |
| 05 Mon Jan 2026 | 4.71 | 4.77 | 4.84 | 4.66 | 0.711 times |
| 02 Fri Jan 2026 | 4.77 | 4.86 | 4.98 | 4.65 | 1.433 times |
| 31 Wed Dec 2025 | 4.81 | 4.61 | 5.05 | 4.59 | 2.73 times |
| 30 Tue Dec 2025 | 4.62 | 4.70 | 4.75 | 4.55 | 0.836 times |
| 29 Mon Dec 2025 | 4.72 | 4.76 | 4.81 | 4.66 | 0.482 times |
| 26 Fri Dec 2025 | 4.78 | 4.77 | 4.82 | 4.66 | 0.534 times |
| 24 Wed Dec 2025 | 4.79 | 4.70 | 4.91 | 4.70 | 0.685 times |
| 23 Tue Dec 2025 | 4.68 | 4.67 | 4.80 | 4.64 | 0.75 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 4.8, but if it comes below 4.8, then a intra day sell could be more profitable.
If you take a sell trade below 4.8, then use 4.8 as stoploss and 4.69 as target. However if you take a buy trade in stock , then use 4.8 as stoploss and 5 as target.
Share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Target | 3.66 |
| Downside Target | 4.08 |
| Downside Target | 4.38 |
| Downside Target | 4.55 |
| Downside Target | 4.65 |
| Downside Target | 4.81 |
| Upside Target | 4.95 |
| Upside Target | 5.00 |
| Upside Target | 5.05 |
| Upside Target | 5.07 |
| Upside Target | 5.10 |
Intraday share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Intraday Target | 4.69 |
| Downside Intraday Target | 4.49 |
| Upside Intraday Target | 5.04 |
| Upside Intraday Target | 5.19 |
| Downside Intraday Target | 4.84 |
Weekly technical analysis of Arbutus Biopharma (ABUS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 07 Wed Jan 2026 | 4.88 | 4.77 | 5.00 | 4.65 | 0.526 times |
| 02 Fri Jan 2026 | 4.77 | 4.76 | 5.05 | 4.55 | 1.806 times |
| 26 Fri Dec 2025 | 4.78 | 4.46 | 4.91 | 4.45 | 0.327 times |
| 19 Fri Dec 2025 | 4.43 | 4.72 | 5.07 | 4.42 | 1.934 times |
| 12 Fri Dec 2025 | 4.71 | 4.43 | 4.81 | 4.38 | 1.092 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Arbutus Biopharma (ABUS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 07 Wed Jan 2026 | 4.88 | 4.86 | 5.00 | 4.65 | 0.169 times |
| 31 Wed Dec 2025 | 4.81 | 4.34 | 5.07 | 4.09 | 1.487 times |
| 28 Fri Nov 2025 | 4.41 | 4.51 | 4.87 | 4.08 | 0.863 times |
| 31 Fri Oct 2025 | 4.73 | 4.55 | 4.95 | 4.10 | 0.669 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arbutus Biopharma (ABUS)
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Arbutus Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Arbutus Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.77 and Arbutus Biopharma (ABUS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Arbutus Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Arbutus Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.77 and Arbutus Biopharma (ABUS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.